Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma

Abstract

The combination of chidamide and anti-programmed cell death 1 (PD-1) therapy represents a potentially important strategy for STS.